
180 Life Sciences Corp. – NASDAQ:ATNF
180 Life Sciences Corp. stock price today
180 Life Sciences Corp. stock price monthly change
180 Life Sciences Corp. stock price quarterly change
180 Life Sciences Corp. stock price yearly change
180 Life Sciences Corp. key metrics
Market Cap | 3.61M |
Enterprise value | N/A |
P/E | -0.07 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | 0.09 |
PEG ratio | N/A |
EPS | -41.58 |
Revenue | N/A |
EBITDA | -10.65M |
Income | -16.24M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for free180 Life Sciences Corp. stock price history
180 Life Sciences Corp. stock forecast
180 Life Sciences Corp. financial statements
Jun 2023 | 0 | -3.68M | |
---|---|---|---|
Sep 2023 | 0 | -10.26M | |
Dec 2023 | 166.03K | -1.22M | -739.09% |
Mar 2024 | 0 | -1.06M |
2025 | 16.64M | -21.60M | -129.84% |
---|---|---|---|
2026 | 30.41M | 21.60M | 71.05% |
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 13666714 | 6.95M | 50.86% |
---|---|---|---|
Sep 2023 | 4958085 | 5.10M | 103.01% |
Dec 2023 | 5259476 | 5.38M | 102.43% |
Mar 2024 | 3441740 | 4.39M | 127.73% |
Jun 2023 | -3.11M | 640.39K | 2.46M |
---|---|---|---|
Sep 2023 | -1.77M | -4.85M | 2.44M |
Dec 2023 | -2.16M | 4.21M | 1.46M |
Mar 2024 | -1.03M | 0 | -264.39K |
180 Life Sciences Corp. alternative data
Aug 2023 | 5 |
---|---|
Sep 2023 | 5 |
Oct 2023 | 5 |
Nov 2023 | 5 |
Dec 2023 | 5 |
Jan 2024 | 5 |
Feb 2024 | 5 |
Mar 2024 | 5 |
Apr 2024 | 5 |
May 2024 | 4 |
Jun 2024 | 4 |
Jul 2024 | 4 |
180 Life Sciences Corp. other data
Period | Buy | Sel |
---|---|---|
May 2023 | 77244 | 0 |
Jun 2023 | 18000 | 0 |
Dec 2023 | 25000 | 25000 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Sale | FELDMANN MARC director | Common Stock | 25,000 | $0.19 | $4,700 | ||
Purchase | WOODY JAMES N. director, officer.. | Common Stock | 25,000 | $0.19 | $4,700 | ||
Purchase | STEINMAN LAWRENCE director | Common Stock | 18,000 | $1.23 | $22,068 | ||
Purchase | MCGOVERN JR. DONALD A. director | Common Stock | 10,000 | $1.15 | $11,470 | ||
Purchase | MCGOVERN JR. DONALD A. director | Common Stock | 5,000 | $1.16 | $5,800 | ||
Purchase | MARRONE PAMELA G director | Common Stock | 7,082 | $1.06 | $7,507 | ||
Purchase | PAMIR OZAN officer: CFO | Common Stock | 5,162 | $1.01 | $5,214 | ||
Purchase | MCGOVERN JR. DONALD A. director | Common Stock | 10,000 | $1.05 | $10,500 | ||
Purchase | WOODY JAMES N. director, officer.. | Common Stock | 40,000 | $1.03 | $41,200 | ||
Purchase | VU QUAN ANH officer: COO / Chief Business O.. | Common Stock | 8,000 | $3.98 | $31,840 |
Insider | Compensation |
---|---|
Dr. Jonathan B. Rothbard Ph.D. (1952) Chief Scientific Officer | $333,970 |
Mr. Ozan Pamir C.F.A. (1992) Interim Chief Financial Officer & Sec. | $299,750 |
Dr. James N. Woody M.D., Ph.D. (1942) Chief Executive Officer & Director | $265,170 |
-
What's the price of 180 Life Sciences Corp. stock today?
One share of 180 Life Sciences Corp. stock can currently be purchased for approximately $7.3.
-
When is 180 Life Sciences Corp.'s next earnings date?
Unfortunately, 180 Life Sciences Corp.'s (ATNF) next earnings date is currently unknown.
-
Does 180 Life Sciences Corp. pay dividends?
No, 180 Life Sciences Corp. does not pay dividends.
-
How much money does 180 Life Sciences Corp. make?
180 Life Sciences Corp. has a market capitalization of 3.61M.
-
What is 180 Life Sciences Corp.'s stock symbol?
180 Life Sciences Corp. is traded on the NASDAQ under the ticker symbol "ATNF".
-
What is 180 Life Sciences Corp.'s primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of 180 Life Sciences Corp.?
Shares of 180 Life Sciences Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are 180 Life Sciences Corp.'s key executives?
180 Life Sciences Corp.'s management team includes the following people:
- Dr. Jonathan B. Rothbard Ph.D. Chief Scientific Officer(age: 73, pay: $333,970)
- Mr. Ozan Pamir C.F.A. Interim Chief Financial Officer & Sec.(age: 33, pay: $299,750)
- Dr. James N. Woody M.D., Ph.D. Chief Executive Officer & Director(age: 83, pay: $265,170)
-
How many employees does 180 Life Sciences Corp. have?
As Jul 2024, 180 Life Sciences Corp. employs 4 workers, which is 20% less then previous quarter.
-
When 180 Life Sciences Corp. went public?
180 Life Sciences Corp. is publicly traded company for more then 8 years since IPO on 27 Jun 2017.
-
What is 180 Life Sciences Corp.'s official website?
The official website for 180 Life Sciences Corp. is 180lifesciences.com.
-
Where are 180 Life Sciences Corp.'s headquarters?
180 Life Sciences Corp. is headquartered at Building 4, Palo Alto, CA.
-
How can i contact 180 Life Sciences Corp.?
180 Life Sciences Corp.'s mailing address is Building 4, Palo Alto, CA and company can be reached via phone at +65 05070669.
180 Life Sciences Corp. company profile:

180 Life Sciences Corp.
180lifesciences.comNASDAQ
4
Biotechnology
Healthcare
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Palo Alto, CA 94306
CIK: 0001690080
ISIN: US68236V3024
CUSIP: 68236V104